company background image
600518 logo

Kangmei Pharmaceutical SHSE:600518 Stock Report

Last Price

CN¥2.31

Market Cap

CN¥32.0b

7D

-2.1%

1Y

19.1%

Updated

24 Nov, 2024

Data

Company Financials

Kangmei Pharmaceutical Co., Ltd.

SHSE:600518 Stock Report

Market Cap: CN¥32.0b

600518 Stock Overview

Produces and sells Chinese herbal medicines in China. More details

600518 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Kangmei Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kangmei Pharmaceutical
Historical stock prices
Current Share PriceCN¥2.31
52 Week HighCN¥2.93
52 Week LowCN¥1.68
Beta0.63
11 Month Change15.50%
3 Month Change28.33%
1 Year Change19.07%
33 Year Change-52.17%
5 Year Change-36.19%
Change since IPO71.25%

Recent News & Updates

Subdued Growth No Barrier To Kangmei Pharmaceutical Co., Ltd. (SHSE:600518) With Shares Advancing 35%

Nov 08
Subdued Growth No Barrier To Kangmei Pharmaceutical Co., Ltd. (SHSE:600518) With Shares Advancing 35%

We Think Kangmei Pharmaceutical's (SHSE:600518) Robust Earnings Are Conservative

Nov 06
We Think Kangmei Pharmaceutical's (SHSE:600518) Robust Earnings Are Conservative

Is Kangmei Pharmaceutical (SHSE:600518) A Risky Investment?

Oct 28
Is Kangmei Pharmaceutical (SHSE:600518) A Risky Investment?

Recent updates

Subdued Growth No Barrier To Kangmei Pharmaceutical Co., Ltd. (SHSE:600518) With Shares Advancing 35%

Nov 08
Subdued Growth No Barrier To Kangmei Pharmaceutical Co., Ltd. (SHSE:600518) With Shares Advancing 35%

We Think Kangmei Pharmaceutical's (SHSE:600518) Robust Earnings Are Conservative

Nov 06
We Think Kangmei Pharmaceutical's (SHSE:600518) Robust Earnings Are Conservative

Is Kangmei Pharmaceutical (SHSE:600518) A Risky Investment?

Oct 28
Is Kangmei Pharmaceutical (SHSE:600518) A Risky Investment?

What Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) P/S Is Not Telling You

Aug 03
What Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) P/S Is Not Telling You

We Think Kangmei Pharmaceutical (SHSE:600518) Can Stay On Top Of Its Debt

Jun 17
We Think Kangmei Pharmaceutical (SHSE:600518) Can Stay On Top Of Its Debt

Kangmei Pharmaceutical's (SHSE:600518) Performance Is Even Better Than Its Earnings Suggest

May 06
Kangmei Pharmaceutical's (SHSE:600518) Performance Is Even Better Than Its Earnings Suggest

Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) Price Is Out Of Tune With Revenues

Apr 10
Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) Price Is Out Of Tune With Revenues

Shareholder Returns

600518CN PharmaceuticalsCN Market
7D-2.1%-1.5%-2.1%
1Y19.1%-9.4%2.8%

Return vs Industry: 600518 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 600518 exceeded the CN Market which returned 2.8% over the past year.

Price Volatility

Is 600518's price volatile compared to industry and market?
600518 volatility
600518 Average Weekly Movement8.0%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 600518 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600518's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19974,409Guowei Liuwww.kangmei.com.cn

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. It also offers chemical medicines and health food; and operates hospitals and pharmacies. Kangmei Pharmaceutical Co., Ltd.

Kangmei Pharmaceutical Co., Ltd. Fundamentals Summary

How do Kangmei Pharmaceutical's earnings and revenue compare to its market cap?
600518 fundamental statistics
Market capCN¥32.03b
Earnings (TTM)CN¥255.55m
Revenue (TTM)CN¥5.21b

125.3x

P/E Ratio

6.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600518 income statement (TTM)
RevenueCN¥5.21b
Cost of RevenueCN¥4.55b
Gross ProfitCN¥665.09m
Other ExpensesCN¥409.54m
EarningsCN¥255.55m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.018
Gross Margin12.76%
Net Profit Margin4.90%
Debt/Equity Ratio0.2%

How did 600518 perform over the long term?

See historical performance and comparison